Microsoft buys genetic data software from Merck
Wall Street Journal, June 3, 2009
Microsoft continued its push into healthcare through a deal with Merck to gain access to some genetic data-management software. Microsoft plans to incorporate the genetic and genomic data-management software into Microsoft Amalga Life Sciences. Amalga is part of a push by Microsoft, whose other offerings include patient health-records holder HealthVault, to become a bigger player in healthcare.